← All companies

TGTX

TG Therapeutics, Inc.

TGTX Nasdaq Pharmaceutical Preparations EDGAR ↗

$46.17

-7.36 -13.75%

Key statistics

from XBRL data in SEC filings

Market cap

$7.07B

Revenue (TTM)

$700M

Net income (TTM)

$462M

EPS (TTM)

$2.86

P/E ratio

16.1

Dividend yield

—

Free cash flow

-$25.0M

Cash

$442M

Total assets

$1.53B

Gross margin

—

52-week range

$25.28 – $59.30

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Results of operations (earnings release) Aug 3, 2026 8-K Shareholder vote results Jun 12, 2026 8-K Other events Jun 3, 2026 8-K Other events May 27, 2026 10-Q Quarter ended 2026-03-31 May 6, 2026 8-K Results of operations (earnings release) May 6, 2026 8-K Entered a material agreement; Took on a direct financial obligation Mar 20, 2026 10-K Fiscal year ended 2025-12-31 Feb 27, 2026 8-K Results of operations (earnings release) Feb 26, 2026 8-K Regulation FD disclosure Jan 13, 2026 10-Q Quarter ended 2025-09-30 Nov 5, 2025 8-K Results of operations (earnings release) Nov 3, 2025 10-Q Quarter ended 2025-06-30 Aug 8, 2025 8-K Results of operations (earnings release) Aug 4, 2025 8-K Shareholder vote results Jun 13, 2025 10-Q Quarter ended 2025-03-31 May 9, 2025 8-K Results of operations (earnings release) May 5, 2025 10-K Fiscal year ended 2024-12-31 Mar 3, 2025 8-K Results of operations (earnings release) Mar 3, 2025 8-K Regulation FD disclosure Jan 14, 2025 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release) Nov 4, 2024 10-Q Quarter ended 2024-06-30 Aug 9, 2024 10-K/A Fiscal year ended 2023-12-31 Aug 9, 2024 8-K Entered a material agreement; Terminated a material agreement; Results of operations (earnings release); Other events Aug 6, 2024 8-K Director or officer change; Amended charter or bylaws; Shareholder vote results Jun 17, 2024 10-Q Quarter ended 2024-03-31 May 6, 2024 8-K Results of operations (earnings release) May 1, 2024 10-K Fiscal year ended 2023-12-31 Feb 29, 2024 8-K Results of operations (earnings release) Feb 28, 2024 8-K Entered a material agreement; Regulation FD disclosure Jan 10, 2024 10-Q Quarter ended 2023-09-30 Nov 6, 2023 8-K Results of operations (earnings release) Nov 1, 2023 10-Q Quarter ended 2023-06-30 Aug 4, 2023 8-K Entered a material agreement; Results of operations (earnings release) Aug 1, 2023 8-K Shareholder vote results Jun 15, 2023 10-Q Quarter ended 2023-03-31 May 8, 2023 8-K Results of operations (earnings release) May 1, 2023 10-K Fiscal year ended 2022-12-31 Mar 1, 2023 8-K Results of operations (earnings release) Feb 28, 2023